Back to Trades
Other4
ENANTA PHARMACEUTICALS INC
ENTA
Total Value
$1.4M
Company Information
- Company Name
- ENANTA PHARMACEUTICALS INC
- Ticker Symbol
- ENTA
- CIK
- 0001177648
Insider Information
- Role
- Chief Product Strategy Officer
- Location
- WATERTOWN, MA
Officer
Filing Details
- Filing Date
- Nov 26, 2025
- Transaction Date
- Nov 25, 2025
- Accession Number
- 0002064832-25-000032
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Nov 25, 2025 | Derivative | 100,000 | $13.66 | Grant/Award | $1.4M |
Footnotes
- (F1)Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 25, 2025).